Cambridge Healthtech Institute’s 6th Annual

Gene Therapy Manufacturing

August 18-19, 2021

With the first gene therapies on the market and many more in clinical development, the race is on to improve viral vector production in line with ever increasing demand.

Cambridge Healthtech Institute’s Gene Therapy Manufacturing conference tackles the practical challenges facing the production, scale-up and manufacture of viral vector-based gene therapies. Topcis include AAV, lentivirus and retrovirus process development, vector development, scale-up and purification for clinical and commmerical supply.

Coverage will include, but is not limited to:;

Production strategies for commercializing gene therapies
Strategies to optimize AAV production
Scale-up strategies
Process intensification
Emerging production technologies
DSP strategies for gene therapies
Gene-edited technical development and manufacture
Manufacturing strategies for rare diseases
Manufacturing strategies for wider indications
Formulation, stability and delivery

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is January 29, 2021.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:

Daniel Barry

Senior Conference Producer

Cambridge Healthtech Institute

Phone: (+44) 7837-651-303

Email: dbarry@healthtech.com

For partnering and sponsorship information, please contact:

Companies A-K

Sherry Johnson

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-972-1359